Randomized evaluation of ticagrelor monotherapy after 3-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with new-generation sirolimus-eluting stents: TICO trial rationale and design-Reference-Cited by-同舟云学术

Randomized evaluation of ticagrelor monotherapy after 3-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with new-generation sirolimus-eluting stents: TICO trial rationale and design

Published:2019-06 Issue: Volume:212 Page:45-52
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Kim Choongki,Hong Sung-Jin,Shin Dong-Ho,Kim Byeong-Keuk,Ahn Chul-Min,Kim Jung-Sun,Ko Young-Guk,Choi Donghoon,Hong Myeong-Ki,Jang Yangsoo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N Engl J Med,2001

2. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes;Wiviott;N Engl J Med,2007

3. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes;Wallentin;N Engl J Med,2009

4. Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2018;39:213–60.

5. Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2016;68:1082–115.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical implication of ticagrelor monotherapy in patients with small vessel coronary artery disease: results from the TICO randomized trial;Frontiers in Cardiovascular Medicine;2023-08-08

2. Body mass index affecting ticagrelor monotherapy vs. ticagrelor with aspirin in patients with acute coronary syndrome: A pre-specified sub-analysis of the TICO randomized trial;Frontiers in Cardiovascular Medicine;2023-03-30

3. Long-term use of clopidogrel versus ticagrelor or prasugrel in patients with acute myocardial infarction after percutaneous coronary intervention;PLOS ONE;2023-02-23

4. P2Y12 Antagonists in Cardiovascular Disease—Finding the Best Balance Between Preventing Ischemic Events and Causing Bleeding;Frontiers in Cardiovascular Medicine;2022-05-12

5. Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy;Circulation: Cardiovascular Interventions;2022-04